NSE · SYNCOMF

Syncom Formulations (India) Limited

Sector: Healthcare · ISIN: INE312C01025

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.

Market cap rank

#1,137

of 5,004 stocks

🏆 New peak

▲ 1021W

Peak #1,137 · 01 Oct 2026

Syncom Formulations (India) Limited is a smallcap company in the Healthcare space and is growing revenue modestly, commands a premium earnings multiple, and earns a healthy return on equity. Ownership as of Jun 2026.

Market Cap

2,357.52 Cr

P/E Ratio

30.96

P/B Ratio

5.69

ROE

18.42%

ROCE

23.77%

Dividend Yield

—

52W High

—

52W Low

—

Quarterly financials

Metric	Q1 2026-27	Q4 2025-26	Q3 2025-26	Q2 2025-26
Revenue	125.53 Cr	135.41 Cr	115.14 Cr	121.72 Cr
Net Profit	24.85 Cr	25.17 Cr	18.91 Cr	16.60 Cr
EPS	0.26	0.27	0.23	0.18
Operating Profit	32.50 Cr	34.08 Cr	25.35 Cr	22.30 Cr

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter

50.57%

Public

49.43%

As of 30 Jun 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

₹0.02

Cr total

Schemes

Fund Houses

₹0.02 Cr

Total Exposure

Motilal Oswal Mutual Fund₹0.02 Cr (100.0%)

Scheme	Fund House	Value (Cr)	%

All MF holders by market value as of 01 Aug 2026.

Recent corporate actions

Ex-Date	Type	Details
23 Sep 2024	Other	Annual General Meeting
18 Sep 2023	Other	Annual General Meeting

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs